Heart Rate Variability and Inflammatory Bowel Disease

Description

The goals of this study are to test the effectiveness of a virtually delivered, group-based coping skills treatment program incorporating heart rate variability biofeedback to target autonomic dysfunction in youth diagnosed with inflammatory bowel disease (IBD). The investigators will enroll participants with IBD in a biofeedback enhanced cognitive behaviorally based coping skills treatment. Participants will be randomized to biofeedback enhanced treatment or wait-list control.

Conditions

Inflammatory Bowel Diseases

Talk to us

Study Overview

On this page

Study Details

Study overview

The goals of this study are to test the effectiveness of a virtually delivered, group-based coping skills treatment program incorporating heart rate variability biofeedback to target autonomic dysfunction in youth diagnosed with inflammatory bowel disease (IBD). The investigators will enroll participants with IBD in a biofeedback enhanced cognitive behaviorally based coping skills treatment. Participants will be randomized to biofeedback enhanced treatment or wait-list control.

A Heart Rate Variability Biofeedback Enhanced Behavioral Intervention to Improve Psychological and Disease Functioning in Youth With Inflammatory Bowel Disease (IBD)

Heart Rate Variability and Inflammatory Bowel Disease

Condition
Inflammatory Bowel Diseases
Intervention / Treatment

-

Contacts and Locations

Atlanta

Atlanta Metropolitan Area, Atlanta, Georgia, United States, 30303

Atlanta

Children's Healthcare of Atlanta, Atlanta, Georgia, United States, 30322

Atlanta

Center for Advanced Pediatrics, Atlanta, Georgia, United States, 30329

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Diagnosis with biopsy-confirmed IBD for at least 4 months,
  • * ages 13 through 18 years inclusive,
  • * speak English,
  • * enrolling with at least 1 parent/guardian who is willing to participate by completing surveys,
  • * positive depression or anxiety screens using the PHQ-4, - access to home internet to participate in virtual intervention,
  • * youth and parent agree to the conditions of study participation, including randomization, participation in intervention, and follow-up assessments,
  • * youth is medically approved to engage in normal daily activities (e.g., attend school, extracurricular activities)
  • * previous diagnosis of developmental disabilities that require full-time special education or that impair the ability to respond to treatment,
  • * diagnosis with any other chronic disease (e.g., diabetes, epilepsy, etc.),
  • * diagnosis of abnormal thyroid function,
  • * treatment with any drug with known autonomic cardiovascular influences including beta-blockers, central sympatholytic agents, or antidepressants.

Ages Eligible for Study

13 Years to 18 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Emory University,

Bonney Reed, PhD, PRINCIPAL_INVESTIGATOR, Emory University

Study Record Dates

2028-10